Neprilysin inhibition: a new therapeutic option for type 2 diabetes?
Esser N, Zraika S
Diabetologia. 2019;62:1113–22
Leggi
Breaking news
Dietary patterns are not associated with brain atrophy or cerebral small vessel disease in older adults with and without type 2 diabetes
Zabetian-Targhi F, Srikanth VK, Smith KJ, et al.
J Nutr. 2019 Jun 29
Leggi
AIFA – FDA approva un nuovo trattamento per i pazienti pediatrici con diabete di tipo 2
27/06/2019
Leggi
Continuous glucose monitoring in pregnant women with type 1 diabetes: an observational cohort study of 186 pregnancies
Kristensen K, Ögge LE, Sengpiel V, et al.
Diabetologia. 2019;62:1143–53
Leggi
Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease
Heerspink HJL, Perco P, Mulder S, et al.
Diabetologia. 2019;62:1154–66
Leggi
High-intensity statins are associated with increased incidence of hypoglycemia during hospitalization of individuals not critically ill
Khanimov I, Segal G, Wainstein J, et al.
Am J Med. 2019 Jun 21
Leggi
Statin Prescription for Patients with Atherosclerotic Cardiovascular Disease from National Survey Data
Vatcheva KP, Aparicio V, Araya A, et al.
Am J Cardiol. 2019;124(1):1-7
Leggi
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
Herold KC, Bundy BN, Long SA, et al.
N Engl J Med. Pub. online 9 June 2019
Leggi
A Reduction in Sedentary Behaviour in Obese Women During Pregnancy Reduces Neonatal Adiposity: The DALI Randomised Controlled Trial
van Poppel MNM, Simmons D, Devlieger R, et al.
Diabetologia. 2019;62:915-925
Leggi
Augmented Insulin Secretory Response in Early Pregnancy
Powe CE, Huston Presley LP, Locascio JJ, et al.
Diabetologia. Pub. Online 9 June 2019
Leggi